SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nestegg who wrote (164)8/10/1998 10:10:00 AM
From: Terry D  Read Replies (1) of 258
 
08/06 8:26A (DJ) +Martek:Study Shows Oil Improve Vision In Term Infants

COLUMBIA, Md. (Dow Jones)--Martek Biosciences Corp. (MATK) said a National Institutes of Health study concludes that early dietary intake of the company's docosahexaenic acid plus arachidonic acid appears necessary for optimal development of the brain and eye.
In a press release Thursday, Martek said the randomized clinical study of 108 term infants showed those fed DHA and AA-supplemented formula had visual development results consistent with breast-fed infants.
The company said infants fed formula without DHA and AA had a deficiency of about "one line on an eye chart" compared to breast milk and DHA plus AA fed babies.
Martek said the study gave "compelling" support for DHA and AA supplementation in infant formulas and said the study suggests that availability of dietary DHA during this critical developmental period may lead to favorable persistent changes in the underlying neural structure and function of infants.
Martek's DHA and AA oils are vegetable oils containing two long-chain polyunsaturated fatty acids, DHA and AA, which are naturally delivered to babies through breast milk.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext